| There’s more at stake with Question 4 in Massachusetts than just one state’s policy toward plant medicines. In private conversations behind closed doors, it’s clear the psychedelic movement lost a ton of momentum following the FDA’s rejection of MDMA. |
| Now funding is drying up, start-ups are folding, and critics are vocally questioning the validity of psychedelic research studies. It’s not just the residents of Massachusetts who need this, it’s the psychedelic movement as a whole. A win here would go a long way toward reinvigorating the flagging movement. |
| But the campaign is down to the wire. Like much of American politics, it’s a tense, even split between the two sides. Polling shows 46.5% Yes to 46% No, with the remaining 7.5% undecided. |
| We’ve covered several stories about Question 4 with expert opinions and high-profile endorsements, so now let’s take a look at the other side. |
| Who is opposing this? And why? Read the full story about the resistance to legalizing psychedelics in Massachusetts here. |
Doubleblind Article: Massachusetts Could Legalize Psychedelic Therapy This Election—But Not Everyone is Onboard
